Sushila Dalal

Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center

Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients

Microbially catalyzed conjugation of GABA and tyramine to bile acids

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

Bile acid fitness determinants of a <i>Bacteroides fragilis</i> isolate from a human pouchitis patient

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch–Anal Anastomosis in Pediatric Ulcerative Colitis

Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes

The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)

Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes

The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease

Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease

Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease

Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease

Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis

Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe

Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion

The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn’s Disease

Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab

Distinct roles of intracellular heat shock protein 70 in maintaining gastrointestinal homeostasis

Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis

Patient-Specific <i>Bacteroides</i> Genome Variants in Pouchitis

Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility

Using Corticosteroids to Reshape the Gut Microbiome

Systematic Review

What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.